This was the stock's eighth consecutive day of losses.

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming MS management across the health care system.

--Longest losing streak since Oct. 27, 2023, when it fell for eight straight trading days --Worst eight day stretch since the eight days ending May 15, 2025, when it fell 9.88% --Down 45.31% from its ...

That’s pushing up the values of companies with a heavy Medicare presence, such as UnitedHealth, Humana and CVS Health, which also reported earnings this morning.

Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...

Meta shareholders abruptly settled an $8 billion lawsuit accusing Mark Zuckerberg and other executives of oversight failures ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Kathmere Capital Management LLC has recently invested $269,000 in CVS Health Corporation, securing a new position with 3,967 ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen ...